Mary Maina: Postpartum Hemorrhage Is Preventable and Treatable
Mary Maina, Co-Convener at Intercounty MPDSR Initiative, County Obstetrician and Gynaecologist at Kiambu County Government, shared a post on LinkedIn:
“Postpartum Hemorrhage is preventable.
Postpartum Hemorrhage is treatable.
At the beginning of the year, the leadership of the department of health committed to support facilities to end deaths from postpartum hemorrhage in the county:
- Availability of blood and blood products through regular, county supported blood drives.
- Availability of uterotonics including heat stable carbetocin, oxytocin and Tranexamic acid in ALL public facilities offering maternity services at All Times.
- Capacity building through regular drills by the EmONC mentors available in the county.
- Monthly MPDSR supportive supervision.
- All level 4 and 5 facilities are supported to stop hemorrhage before referral. Specialist Obstetricians were posted to each and every level 4 hospital to support this, for the woman who needs surgical intervention.
- Blood moves to the patient, not the patient to blood since January 2026.
- Level 3 facilities supported through mentorships and regular reminders to Refer in Good time.
- Dedicated Ambulance for maternal and newborn referrals. More efforts still going into improving the TAT for referrals.
- Fidelity to the Golden Hour of PPH. Regular remimders in the whatsapp groups to Act Fast, Refer Early.
While there is still alot to be done, this is an unprecedented record. And it didnt happen by chance. The healthworkers and the leadeship have demonstrated Deliberate efforts to keep mothers and newborns alive.
(We lost one to Antepartum hemorrhage (APH) at 29 weeks of pregnancy. Her loss will not be in vain, and tge lessons learnt will save those we can).
Teamwork wins any day.
A very special appreciation to our county Director Hillary Kagwa for wholeheartedly supporting the healthworkers in their efforts to keep mothers and newborns alive.”
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 14, 2026, 06:26Delivering Gene Therapy in Hemophilia – ISTH
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials